DOCSLIB.ORG

February 2010

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
February 2010 Updated 06.21.2021 CURRICULUM VITAE Gary S. Francis, M.D., F.A.C.C., F.A.H.A., F.A.C.P., F.H.F.S.A. U.S. Citizen Office Physical Address: Office Mailing Current Position: University of Minnesota Address: Professor Emeritus Variety Club Research 420 Delaware Street, University of Minnesota Center SE Cardiovascular Division MMC 508 401 East River Road Minneapolis, MN Minneapolis, MN 55455 55455 Direct Phone: (612) 626- 4895 Office Phone: (612) 624- 8970 FAX: (612) 626-4411 E-mail: [email protected] Exec.Administrator, Kitty Tincher Education: Degree Institution Date Degree Granted None University of Minnesota (1963-1965) None Honors Course MD Creighton University School of Medicine 1969 (early entry, 2 scholarships, AOA) Internship Creighton University School of Medicine 1969-1970 and Affiliated Hospitals Residency in Internal Medicine U.S. Navy 1970-1972 CV Disease Fellowship Naval Regional Medical Center 1972-1974 San Diego, California National Awards Master Teacher Award – University of Miami – May 26, 1996 Master Teacher Award – University of Miami – May 25, 2002 Annual Laennec Clinician Educator Award – American Heart Association – November 2006 Distinguished Teacher Award – American College of Cardiology – March 21, 2014 Lifetime Achievement Award – Heart Failure Society of America – September 15, 2014 Scholarly Overview Total publications – 560 (about 14-15 papers per year) h-index – 88, 83, 84 (various services) Total citations – 50,946 Views on internet – 382,539 (Mendeley) First/last author citations – 7740 Top 1% of scientists world-wide, as noted by Heart Failure Society of America using SCOPUS 2019 Academic Appointments: Professor Emeritus – University of Minnesota January 1, 2021 Gary S. Francis, M.D. Curriculum Vitae Executive Medical Director - Cardiovascular Service Line-M-Heart (Univ 2014-2018 MN and Fairview affiliated hospitals) Fred C. and Katherine B. Andersen Foundation Chair in Adult Clinical Cardiology, University of Minnesota 2014 - 2017 Professor of Medicine with tenure – University of Minnesota, 2008-2020 Cardiovascular Division Professor of Medicine – Cleveland Clinic Lerner College of Medicine of Case Western Reserve University 2004 - 2008 Professor of Medicine, Ohio State University, Health Sciences Center 1999 - 2004 Professor of Medicine, University of Minnesota Medical School 1988 - 1997 Associate Professor of Medicine, University of Minnesota Medical School 1982 - 1988 Director, Echo Laboratory VA Medical Center, Minneapolis, MN 1980 - 1988 Principal Investigator VA Cooperative Study on Vasodilator Therapy in 1979 - 1985 Congestive Heart Failure (V-HeFT I) - University of Minnesota Associate Chairman and Principal Investigator VA Cooperative Study on 1979 - 1982 Vasodilator Therapy of Acute Myocardial Infarction - VA Hospital; Minneapolis, Minnesota; University of Minnesota Assistant Professor of Medicine, University of Minnesota Medical School 1977 - 1982 Director, George E. Fahr Cardiac Care Unit, Hennepin County Medical 1977 - 1979 Center; University of Minnesota Clinical Instructor in Medicine, University of California, San Diego, School 1976 - 1977 of Medicine Naval Regional Medical Center, San Diego, CA - Branch Head: 1976 - 1977 Department of Critical Care (1500-bed major tertiary teaching hospital) Academic Administrative Appointments: Interim Chief of Cardiology, University of Minnesota 2014 - 2017 Executive Medical Director, Cardiovascular Service Line, MHealth 2014 - 2017 Associate Director, Lillehei Clinical Research Unit – University of Minnesota 2009 - 2014 Interim Head, Heart Failure and Heart Transplantation – University of Minnesota 2009 - 2014 Head, Clinical Cardiology Section, Cleveland Clinic Foundation 2004 - 2008 Ad Hoc Committee Membership on Tenure and Promotion - Harvard Medical 2016- School Clinical/Hospital Appointments: Chairman, Management Committee and Executive Medical Director of the 2014-2018 Cardiovascular Service Line for University of Minnesota Hospital and Fairview affiliated hospitals Associate Director – General Clinical Research Center (NIH) Cleveland Clinic 2003 - 2004 Foundation (co-PI of Grant) Director, Coronary Intensive Care Unit, Cleveland Clinic Foundation 1997 - 2004 Director, Acute Cardiac Care, University of Minnesota Hospitals and Clinics 1990 - 1997 Research Director, Rasmussen Heart Failure Treatment Center, University of 1994 - 1997 Minnesota Director of Cardiovascular Research, VA Medical Center, Minneapolis, MN 1979 - 1989 Director, George Fahr Coronary Care Unit, HCMC, Minneapolis, MN 1977 - 1979 Director, CCU and Branch Head of Critical Care; Naval Regional Medical Center, 1976-1977 San Diego Consulting Positions: 2 Gary S. Francis, M.D. Curriculum Vitae Member, Lillehei Heart Institute 2009- Steering Committee, Lillehei Heart Institute 2009 - 2016 Current Membership and Offices in Professional Organizations: American Heart Association - Fellow 1977- American College of Cardiology - Fellow 1977- Heart Failure Society of America – President 2004-2006 Editor-in-Chief, Journal of Cardiac Failure 2010-2014 American College of Physicians - Fellow 1977- Heart Failure Society of America, Founding Member, Fellow 1996 Certification, Licenses: National Board of Medical Examiners 1970-present American Board of Internal Medicine #37025 1972-present American Board of Internal Medicine, Subspecialty - Cardiovascular Disease #37025 1975-present Minnesota License Number #23871 2008-present American Board of Internal Medicine - Advanced Heart Failure /Heart Transplant #37025 2010-present Endowed Lectureships (18) Experimental left ventricular remodeling: molecular and physiological considerations. Survival trials in congestive heart failure. University of Toronto Center for Cardiovascular Research Distinguished Speaker Series. Toronto, Ontario, Canada. May 3, 1994. 25th Annual Richter Lecture: “Looking back 20 years and forward 20 years at heart failure.” University of Indiana. December 8th, 2000. Indianapolis, IN Vincent Runco Visiting Professor Lecture. “History of Heart Failure Research: Have we reached certain limits?” April 16 –19th, 2002. Creighton University The Dr. Salomon Jorge Lecture- Lessons from Heart Failure Mega Trials. XIX Congress of Dominican Republic Cardiology. Santo Domingo, Dominican Republic. August 21, 2003 Presidential Address- Heart Failure Society of America-Annual Meeting “Creativity and Science”; Seattle, Washington, Sept 11, 2006 Distinguished Lecture Series – University of British Columbia, Vancouver, Canada. Nov. 3, 2006 William Gaasch, M.D. Lecture – University of Massachusetts; Worcester, Massachusetts, October 12, 2006 Annual AHA Laennec Lecturer – The Treatment of Acute Decompensated Heart Failure in 2006; AHA Meeting, Nov. 2006; Chicago, IL Ehlers Visiting Cardiovascular Research Professor – Mayo Clinic, Nov 28-29th, 2007 (John Burnett's laboratory) Ehlers Visiting Professor – How the heart and the kidney communicate. Mayo Clinic; Rochester, MN. Nov 28-29, 2007. 3 Gary S. Francis, M.D. Curriculum Vitae James F. Sullivan Visiting Professorship and Lecture: The Cardiorenal Syndrome. – March 4, 5, 2008. Creighton University. Annual Paul Wood Speaker – Imperial College, London, U.K. October 3, 2008. (invited by Prof. Philip Poole-Wilson) Annual Jay N. Cohn Lecture – The Cardiorenal Syndrome. April 30th, 2009. University of Minnesota. Earl Bakken Lecture, Bakken Heart-Brain Institute, Cleveland Clinic; Neurohormonal Control of Cardiac Function; March 26, 2010. Earl Bakken Lecture – Neurohumoral Control of Cardiac Function; Cleveland Clinic, Cleveland, OH. March 26, 2010. Annual Champion Lecture Series – Harvard University Massachusetts General Hospital – May 26, 2010 - Cardiorenal Syndrome Brigham and Women’s Hospital – May 27, 2010 - How the Heart and the Kidneys Communicate James K. Alexander Annual Visiting Professorship and Lecture. Baylor University Medical School. April 22-23, 2012. Houston, Texas Gottlieb Lecture, Heart Failure with Preserved Ejection Fraction, Mid-America Heart Institute, Kansas City, MO. October 29, 2015 Visiting Professorships and Invited Grand Rounds (University and Major Teaching Hospitals only): 108 (First 19 not recorded) 20. Problems in Measuring Efficacy of Therapy in CHF. University of Miami, Jackson Memorial Hospital, Miami, FL. August 1987. 21. Neurohumoral Mechanisms in Congestive Heart Failure. Albert Einstein College of Medicine, Bronx, NY. March 1988. 22. Congestive Heart Failure: From Bench to Bedside. Mayo Clinic, Rochester, MN. April 1989. 23. The Sympathetic Nervous System in Congestive Heart Failure. Brigham and Womens’ Hospital. Harvard Medical School, Boston, MA. September 1989. 24. Neurohumoral Abnormalities in Congestive Heart Failure. University of Missouri, Columbia, OH. September 1989. 25. Molecular Biology of Neurohormone Induced Remodeling. University of Alberta, Edmonton, Canada, February 2, 1990. 26. Pathophysiology of Congestive Heart Failure. Hahnamann University Medical Center, Philadelphia, PA. April 8, 1990. 27. Basic Mechanisms of Left Ventricular Remodeling, University of Virginia, Charlottesville, VA. March 13, 1990. 28. Neuroendocrine Influences on Left Ventricular Remodeling, University of Arizona, Tucson, AZ. July 12, 1990. 29. Neuroendocrine Mechanisms in Congestive Heart Failure, Yale University, New Haven, CT. November 1, 1990. 4 Gary S. Francis, M.D. Curriculum Vitae 30. Neuroendocrine Mechanisms of Left Ventricular Remodeling, University of California, San Francisco, CA. April 20, 1991. 31. Left Ventricular Remodeling and Hypertrophy in Response
Load more

Recommended publications
  • ASM Journals Eliminate Impact Factor Information from Journal Websites
    ASM Journals Eliminate Impact Factor Information from Journal Websites The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Casadevall, A., S. Bertuzzi, M. J. Buchmeier, R. J. Davis, H. Drake, F. C. Fang, J. Gilbert, et al. 2016. “ASM Journals Eliminate Impact Factor Information from Journal Websites.” mSphere 1 (4): e00184-16. doi:10.1128/mSphere.00184-16. http:// dx.doi.org/10.1128/mSphere.00184-16. Published Version doi:10.1128/mSphere.00184-16 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:27822275 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA EDITORIAL crossmark ASM Journals Eliminate Impact Factor Information from Journal Websites Arturo Casadevall,a Editor in Chief, mBio®, Stefano Bertuzzi,b Chief Executive Officer, ASM, Michael J. Buchmeier,c Editor in Chief, Microbiology and Molecular Biology Reviews®, Roger J. Davis,d Editor in Chief, Molecular and Cellular Biology®, Harold Drake,e Editor in Chief, Applied and Environmental Microbiology®, Ferric C. Fang,f Editor in Chief, Infection and Immunity®, Jack Gilbert,g Editor in Chief, mSystems™, Barbara M. Goldman,b Director, Journals, ASM, Michael J. Imperiale,h Editor in Chief, mSphere™, Philip Matsumura,i Editor, Genome Announcements™, Alexander J. McAdam,j Editor in Chief, Journal of Clinical Microbiology®, Marcela F. Pasetti,k Editor in Chief, Clinical and Vaccine Immunology®, Rozanne M.
    [Show full text]
  • Holmes Washington 0250E 22
    ©Copyright 2020 Daniel Holmes Identification of Targetable Vulnerabilities During Latent KSHV Infection Daniel Holmes A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2020 Reading Committee: Michael Lagunoff, Chair Adam Philip Geballe Jason G Smith Program Authorized to Offer Degree: Department of Microbiology University of Washington Abstract Identification of Targetable Vulnerabilities During Latent KSHV Infection Daniel Holmes Chair of the Supervisory Committee: Professor Michael Lagunoff Department of Microbiology Viruses are defined as obligate intracellular parasites that require host processes to repli- cate. Latent virus life cycles are no exception to this definition, as viruses are still reliant on host machinery for continued proliferation and maintenance of viral genomes, even in the absence of lytic replication. In this thesis, I used essentiality screening to identify host factors on which Kaposi's Sarcoma Associated Herpesvirus (KSHV) relies for the proliferation and survival of latently infected cells. KSHV is the etiological agent of Kaposi's Sarcoma (KS), an endothelial cell-based tumor where more than 90% of the endothelial cells in the tumor are latently infected with KSHV. While traditional therapies for herpesviruses target lytic replication, the prevalence of latency in KS necessitates exploration of options for intervening in this stage of the viral life cycle. I performed CRISPR/Cas9 screening using lentiviral vec- tors encoding a library of single guide RNAs (sgRNAs) targeting every protein coding gene in the human genome. I compared mock infected and KSHV infected endothelial cells eight days post infection to identify genes essential to latent KSHV infection.
    [Show full text]
  • Editors' Statement on Considerations of Biodefence and Biosecurity
    EDITORIAL Editors’ statement on considerations of biodefence and biosecurity The threat of bioterrorism requires active consideration by scientists. On 9 January 2003, the US National Academy of Sciences held a discussion on the balance between scientific openness and security. The next day, a group of editors met to discuss the issues with specific reference to the scientific publication process. The following statement has emerged from that meeting. The principles dis- cussed will be considered and followed through by Nature Medicine The process of scientific publication, is a view, shared by nearly all, that there is FOURTH: We recognize that on occasions through which new findings are reviewed information that, although we cannot an editor may conclude that the potential for quality and then presented to the rest now capture it with lists or definitions, harm of publication outweighs the poten- of the scientific community and the pub- presents enough risk of use by terrorists tial societal benefits. Under such circum- lic, is a vital element in our national life. that it should not be published. How and stances, the paper should be modified, or New discoveries reported in research pa- by what processes it might be identified not be published. Scientific information is pers have helped improve the human con- will continue to challenge us, because – as also communicated by other means: semi- dition in myriad ways: protecting public all present acknowledged — it is also true nars, meetings, electronic posting, etc. health, multiplying agricultural yields, that open publication brings benefits not Journals and scientific societies can play fostering technological development and only to public health but also in efforts to an important role in encouraging investi- economic growth, and enhancing global combat terrorism.
    [Show full text]
  • Table of Contents (PDF)
    December 30, 2014 u vol. 111 u no. 52 u 18401–18800 Cover image: Pictured are Konik horses, a semiferal breed, at a nature reserve in Oostvaar- dersplassen, Holland. Mikkel Schubert et al. sequenced the DNA from ancient horse bones and compared it to the genomes of five modern domesticated breeds and the only living wild horse species, Przewalski’s horse. Phylogenetic analysis revealed that domesticated breeds likely derived at least partially from the ancient populations. In addition, genes involved in muscle, limb, joint, and cardiac system development, and in social behavior, learning capa- bilities, fear response, and agreeableness were favored during domestication, indicating adaptations that may have resulted from human use and taming. See the article by Schubert et al. on pages E5661–E5669. Image courtesy of Ruben Smit (photographer). From the Cover E5661 Genetics of horse domestication 18460 Dating mastodon extinction 18524 Ethnic diversity and price bubbles 18530 Gulf of Mexico hypoxic zone 18709 Plague bacteria and flea hosts Contents REVIEWER ACKNOWLEDGMENT (ONLINE ONLY) E5724 Acknowledgment of Reviewers, 2014 THIS WEEK IN PNAS SCIENCE AND CULTURE—How science intersects with culture 18401 In This Issue 18403 Science and Culture: Q&A with Roger Malina Maggie McKee LETTERS (ONLINE ONLY) COMMENTARIES E5602 Incorrect representation of Barrier Canyon rock art site’s history and other factors invalidate reported dates Nancy Simon and Richard Reed 18405 The curious case of the Arctic mastodons Duane Froese E5604 Reply to Simon and Reed: Independent and converging See companion article on page 18460 results rule out historic disturbance and confirm age constraints for Barrier Canyon rock art 18407 Downsides of social capital Joel L.
    [Show full text]
  • Uncensored Exchange of Scientific Results
    Correction EDITORIAL Correction for “Uncensored exchange of scientific results,” by Journal Editors and Authors Group, which appeared in issue 4, February 18, 2003, of Proc Natl Acad Sci USA (100:1464; first published February 15, 2003; 10.1073/pnas.0630491100). Due to a printer’s error, the author name “Steven Salzburg” should instead appear as “Steven Salzberg.” Additionally, the affiliation for Steven Salzberg should instead appear as “The Institute for Genomic Research.” The corrected group author footnote appears below. The online version has been corrected. *Group members: Ronald Atlas, President, ASM, and Editor, CRC Critical Reviews in Mi- crobiology; Philip Campbell, Editor, Nature; Nicholas R. Cozzarelli, Editor, PNAS; Greg Curfman, Deputy Editor, New England Journal of Medicine; Lynn Enquist, Editor, Journal of Virology; Gerald Fink, Massachusetts Institute of Technology; Annette Flanagin, Man- aging Senior Editor, Journal of the American Medical Association, and President, Council of Science Editors; Jacqueline Fletcher, President, American Phytopathological Society; Elizabeth George, Program Manager, National Nuclear Security Administration, Depart- ment of Energy; Gordon Hammes, Editor, Biochemistry; David Heyman, Senior Fellow and Director of Science and Security Initiatives, Center for Strategic and International Studies; Thomas Inglesby, Editor, Biosecurity and Bioterrorism; Samuel Kaplan, Chair, ASM Pub- lications Board; Donald Kennedy, Editor, Science; Judith Krug, Director, Office for Intel- lectual Freedom, American Library
    [Show full text]
  • 20.2 Leader 771
    editorials Statement on the consideration of biodefence and biosecurity As discussed in a Commentary by Tony Fauci on page 787, the threat of bioterrorism requires active consideration by scientists. On 9 January 2003, the US National Academy of Sciences held a discussion meeting on the balance between scientific openness and security (see Nature 421, 197; 2003). The next day, a group of editors met to discuss the issues with specific reference to the scientific publication process. The following statement has emerged from that meeting. The statement was conceived in a US context, but the principles discussed will be considered and followed through by Nature and its related journals in their international arenas. he process of scientific publication, through which new find- information, but also recognize that research in the very same ings are reviewed for quality and then presented to the rest fields will be critical to society in meeting the challenges of Tof the scientific community and the public, is a vital element defence. We are committed to dealing responsibly and effectively in our national life. New discoveries reported in research papers with safety and security issues that may be raised by papers have helped improve the human condition in myriad ways: protect- submitted for publication, and to increasing our capacity to ing public health, multiplying agricultural yields, fostering techno- identify such issues as they arise. logical development and economic growth, and enhancing global Third: Scientists and their journals should consider the appropriate stability and security. level and design of processes to accomplish effective review of But new science, as we know, may sometimes have costs as well as papers that raise such security issues.
    [Show full text]
  • Activation of the JC Virus Tat- Response Transcriptional Control
    Corrections Proc. Natl. Acad. Sci. USA 94 (1997) 9511 Microbiology. In the article “Activation of the JC virus Tat- Physiology. In the article “Activation of heteromeric G pro- response transcriptional control element by association of the tein-gated inward rectifier K1 channels overexpressed by Tat protein of human immunodeficiency virus 1 with cellular adenovirus gene transfer inhibits the excitability of hippocam- protein Pura” by Chavdar P. Krachmarov, Lara G. Chepenik, pal neurons” by Markus U. Ehrengruber, Craig A. Doupnik, Sharon Barr-Vagell, Kamel Khalili, and Edward M. Johnson, Youfeng Xu, Justine Garvey, Mark C. Jasek, Henry A. Lester, which appeared in number 24, November 26, 1996, of Proc. and Norman Davidson, which appeared in number 13, June 24, Natl. Acad. Sci. USA (93, 14112–14117), the authors wish to 1997, of Proc. Natl. Acad. Sci. USA (94, 7070–7075), the note that the sequences of two deletion mutants were incor- authors wish to correct the institutional affiliation of Dr. D. E. rectly described. In the left column on page 14116, lines 13–16 Clapham, which was printed incorrectly on page 7070 as should read: “We have tested the effect of two additional Pura McMaster University. Dr. Clapham’s correct affiliation is mutants on transactivation of the JVC late promoter in vivo. Harvard University Medical School. One mutant, Pura 1-215, is illustrated in Fig. 3. The other mutant was PuraD72-216.” The last three sentences of this paragraph should be deleted. Please note that the experiments mentioned in this correction were not included in any of the figures or tables and were not mentioned elsewhere in the text.
    [Show full text]
  • The Host Exosome Pathway Underpins Biogenesis of the Human
    RESEARCH ARTICLE The host exosome pathway underpins biogenesis of the human cytomegalovirus virion Declan L Turner1, Denis V Korneev2, John G Purdy3, Alex de Marco4,5,6, Rommel A Mathias1,4* 1Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Victoria, Australia; 2School of Biological Sciences, Monash University, Victoria, Australia; 3Department of Immunobiology and BIO5 Institute, University of Arizona, Tucson, United States; 4Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Victoria, Australia; 5ARC Centre of Excellence in Advanced Molecular Imaging, Monash University, Victoria, Australia; 6University of Warwick, Coventry, United Kingdom Abstract Human Cytomegalovirus (HCMV) infects over half the world’s population, is a leading cause of congenital birth defects, and poses serious risks for immuno-compromised individuals. To expand the molecular knowledge governing virion maturation, we analysed HCMV virions using proteomics, and identified a significant proportion of host exosome constituents. To validate this acquisition, we characterized exosomes released from uninfected cells, and demonstrated that over 99% of the protein cargo was subsequently incorporated into HCMV virions during infection. This suggested a common membrane origin, and utilization of host exosome machinery for virion assembly and egress. Thus, we selected a panel of exosome proteins for knock down, and confirmed that loss of 7/9 caused significantly less HCMV production. Saliently, we report that *For correspondence: VAMP3 is essential for viral trafficking and release of infectious progeny, in various HCMV strains [email protected] and cell types. Therefore, we establish that the host exosome pathway is intrinsic for HCMV Competing interests: The maturation, and reveal new host regulators involved in viral trafficking, virion envelopment, and authors declare that no release.
    [Show full text]
  • Journal of Virology
    JOURNAL OF VIROLOGY VOLUME 36 0 NUMBER 3 0 DECEMBER 1980 EDITORIAL BOARD Robert R. Wagner, Editor-in-Chief (1982) University of Virginia School ofMedicine, Charlottesville Dwight L. Anderson, Editor (1983) Harold S. Ginsberg, Editor (1984) School of Dentistry, Columbia University University ofMinnesota, New York, N. Y. Minneapolis David T. Denhardt, Editor (1982) Edward M. Scolnick, Editor (1982) University of Western Ontario National Cancer Institute London, Ontario, Canada Bethesda, Md. David Baltimore (1981) Nancy Hopkins (1980) Fred Rapp (1981) Amiya K. Baaerjee (1982) Calderon Howe (1982) Dan S. Ray (1980) jeaneth 1. Berns (1982) Alice S. Huang (1981) M. E. Reicn (1982) IH. L Bishop (1982) D. C. Kelly (1982) Bernard E. Reilly (1980) DavlW9otstein (1982) Tlomas J. Kelly, Jr. (1982) Willham S. Robinson (1980) Michael A. Bratt (1980) George Khoury (1981) Benard Ro (1982) Dennis T. Brown (1981) Jonathan A. King (1981) Roland R. Rueckert (1982) Ahmad 1. Bukhari (1981) David W. Kingsbury (1982) Norman P. Salman (1981) Purnell Choppin (1980) Lloyd M. Kozloff (1982) Joseph Sambook (1982) John M. Coffin (1980) Robert M. Knig (1980) Priscila A. Schaffer (1981) Richard W. Compans (1982) Robert A. L i 1981) Sondra S ger (1980) Geoffrey M. Cooper (1981) Richard A. Lerner (1981) Phlp A. Sharp (1982) Nicbolas R. Cozzarelli (1980) Myron Levine (1982) Aaron J. Shatkln (1982) Clive Dickson (1981) Tomas Lindahl (1981) Saul J. Silverstein (1982) Walter Doerfier (1980) David M. Livingston (1980) Lee D. Simon (1981) Harrison Echols (1981) Ronald B. Luftig (1981) Kai Simn (1981) Elvera Ebrenfeld (1980) Robert MartiDn (1981) Alan E. Smith (1980) Robert N.
    [Show full text]
  • Macdonald CV 2020-02-06
    Curriculum vitae CLINTON C. MACDONALD, PH. D. ADDRESS Department of Cell Biology & Biochemistry Texas Tech University Health Sciences Center 3601 4th Street Lubbock, TX 79430-6540 CONTACT +1-806-743-2524 [email protected] PERSONAL Born April 18, 1958, Memphis, Tennessee, USA EDUCATION Ph. D., Molecular Biology and Biochemistry, State University of New York at Stony Brook, Stony Brook, NY, 1990 B. A., Biology, Middlebury College, Middlebury, VT, 1980 PROFESSIONAL EXPERIENCE 2012–present Professor with tenure, Department of Cell Biology & Biochemistry, Texas Tech University Health Sciences Center 2015–2019 Associate Chair, Department of Cell Biology & Biochemistry, Texas Tech University Health Sciences Center 2002–2012 Associate Professor with tenure, Department of Cell Biology & Biochemistry, Texas Tech University Health Sciences Center 2003–present Associate Professor, Program in Biotechnology, Texas Tech University Health Sciences Center 2000–2009 Director, Summer Undergraduate Biomedical Research (SABR) Program 1997–2002 Assistant Professor, Southwest Cancer Center, Texas Tech University Health Sciences Center 1995–2002 Assistant Professor, Department of Cell Biology & Biochemistry, Texas Tech University Health Sciences Center 1993–1995 Associate, Howard Hughes Medical Institute, Princeton University 1990–1993 American Cancer Society Postdoctoral Fellow, Dr. Thomas Shenk, Department of Molecular Biology, Princeton University 1983–1989 Graduate Research Assistant, Dr. David L. Williams, Molecular Biology Graduate Program, State
    [Show full text]
  • Nucleosome Maps of the Human Cytomegalovirus Genome Reveal a Temporal Switch in Chromatin Organization Linked to a Major IE Protein
    Nucleosome maps of the human cytomegalovirus genome reveal a temporal switch in chromatin organization linked to a major IE protein Einat Zalckvara,b, Christina Paulusc, Desiree Tilloa,b, Alexandra Asbach-Nitzschec, Yaniv Lublinga, Carla Winterlingc,1, Nicholas Striederc,2, Katrin Mückec, Felicia Goodrumd, Eran Segala,b,3, and Michael Nevelsc,3 Departments of aComputer Science and Applied Mathematics and bMolecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel; cInstitute for Medical Microbiology and Hygiene, University of Regensburg, 93053 Regensburg, Germany; and dDepartment of Immunobiology, BIO5 Institute, University of Arizona, Tucson, AZ 65721 Edited* by Thomas Shenk, Princeton University, Princeton, NJ, and approved June 27, 2013 (received for review March 25, 2013) Human CMV (hCMV) establishes lifelong infections in most of us, Human CMV (hCMV), one of eight human herpesviruses, causing developmental defects in human embryos and life-threat- establishes lifelong infections in most people worldwide. The ening disease in immunocompromised individuals. During produc- virus is best known for causing developmental defects in human tive infection, the viral >230,000-bp dsDNA genome is expressed embryos and major disease or death in immunocompromised widely and in a temporal cascade. The hCMV genome does not individuals, including AIDS, cancer, and transplant patients carry histones when encapsidated but has been proposed to form (14, 15). hCMV is among the largest and most complex viruses presently known. During productive infection of human cells, the nucleosomes after release into the host cell nucleus. Here, we ∼ present hCMV genome-wide nucleosome occupancy and nascent viral 235,000-bp dsDNA genome is expressed extensively and in transcript maps during infection of permissive human primary a temporal cascade of immediate-early (IE), early, and late transcription.
    [Show full text]
  • DEPARTMENT of MEDICINE 2016 Annual Report DIVISIONS and INSTITUTES
    DEPARTMENT OF MEDICINE 2016 Annual Report DIVISIONS AND INSTITUTES The Divisions » Allergy John Ohman, MD » Cardiology James Udelson, MD » Clinical Decision Making» John Wong, MD » Clinical Nutrition Edward Saltzman, MD »» »Endocrinology Ron Lechan, MD » Gastroenterology Joel Weinstock, MD » Geographic Medicine and Infectious Disease David Snydman, MD » Hematology/Oncology Andrew Evens, DO » Internal Medicine and Adult Primary Care Deborah Blazey-Martin, MD » Nephrology Andrew Levey, MD » Pulmonary, Critical Care and Sleep Medicine Nicholas Hill, MD » Rheumatology Timothy McAlindon, MD The Institutes » Institute for Clinical Research and Health Policy Studies Harry Selker, MD » Molecular Cardiology Research Institute Richard Karas, MD, PhD » Molecular Oncology Research Institute Philip Tsichlis, MD Photography by Martha Stewart Photography. Design and production by Mark Vincent Communications, Inc. — www.markvincent.net. TABLE OF CONTENTS The Department of Medicine Chairman’s Message 4 Departmental Leadership 6 Departmental Organization Chart 7 Clinical Activity 11 Research Activity 13 Internal Medicine Training Program 15 The Divisions Allergy 18 Cardiology 20 Clinical Care Research 36 Clinical Decision Making 38 Clinical Nutrition 42 Endocrinology, Diabetes and Metabolism 46 Gastroenterology 54 Geographic Medicine and Infectious Diseases 60 Hematology/Oncology 72 Internal Medicine and Adult Primary Care 88 Geriatrics 96 William B. Schwartz Division of Nephrology 98 Pulmonary, Critical Care and Sleep Medicine 106 Rheumatology 114 The Institutes Institute for Clinical Research and Health Policy Studies 124 Molecular Cardiology Research Institute (MCRI) 138 Molecular Oncology Research Institute (MORI) 148 Publications 152 3 CHAIRMAN’S MESSAGE It is with pleasure that I offer the Annual Report for the Department of Medicine for 2016, a year that ended with a major strategic accomplishment for Tufts Medical Center.
    [Show full text]